Funded Startups in Kongens Lyngby
The disclosed rounds in Kongens Lyngby span from 2021-04-09 (Abzu, AI, Seed, $6M) to 2025-06-17 (Droplet IV, Health Care, Seed, $2M).
The disclosed rounds in Kongens Lyngby span from 2021-04-09 (Abzu, AI, Seed, $6M) to 2025-06-17 (Droplet IV, Health Care, Seed, $2M). The largest disclosed round is NIL Technology ApS on 2024-05-07 at $31M, which is in the same general range as Aquaporin’s $25M (2024-04-25) and Reshape Biotech’s $20M (2024-04-09), while most other disclosed amounts sit far below that ceiling (e.g., Konsolidator at $850K on 2024-05-03).
Several entries cluster tightly in spring 2024: four of the 10 rows have round dates between 2024-04-09 and 2024-05-07, including multiple large disclosed rounds (Aquaporin $25M; Reshape Biotech $20M; NIL Technology ApS $31M). Sector-wise, Biotechnology appears 3 times (Aquaporin 2024-04-25 $25M; Rehaler 2023-06-23 undisclosed; plus its pairing with other biotech-adjacent signals via Reshape Biotech), and the listing also includes two amounts marked “undisclosed” (AgriRobot on 2024-12-11; Rehaler on 2023-06-23).
Most recent rounds
10 shownRelated listings
Frequently asked
What’s the largest disclosed funding amount in Kongens Lyngby, and how does it compare to the rest of the disclosed rounds shown?
NIL Technology ApS’s $31M (2024-05-07, “Series Unknown”) is the top disclosed amount and sits above the next-largest disclosed rounds: Aquaporin at $25M (2024-04-25) and Reshape Biotech at $20M (2024-04-09). The remaining disclosed amounts are much smaller in scale, including $15M for ATLANT 3D Nanosystems (2025-03-11) and $2M for Droplet IV (2025-06-17).
Do any rounds cluster into a narrow time window rather than being evenly spread out?
Yes. Four of the 10 rows fall between 2024-04-09 and 2024-05-07 (Reshape Biotech $20M on 2024-04-09; Aquaporin $25M on 2024-04-25; Konsolidator $850K on 2024-05-03; NIL Technology ApS $31M on 2024-05-07). That spring 2024 burst includes multiple of the largest disclosed amounts in the list.
Are there notable outliers among disclosed amounts or via undisclosed entries?
Among disclosed rounds, the main outlier is the $31M NIL Technology ApS round (2024-05-07), which is materially above most other disclosed values such as $6M for Abzu (2021-04-09) and $2M for Droplet IV (2025-06-17). Separately, two companies have “undisclosed” amounts (AgriRobot on 2024-12-11 and Rehaler on 2023-06-23), so comparisons involving those rows can’t be made by dollar amount.
How does stage classification look across the most recent 10 entries?
“Series Unknown” appears 4 times (NIL Technology ApS on 2024-05-07 at $31M; Konsolidator on 2024-05-03 at $850K; Aquaporin on 2024-04-25 at $25M; and LED iBond on 2023-11-29 at $810K). The named stages are otherwise spread out: Seed appears for Droplet IV (2025-06-17, $2M) and Abzu (2021-04-09, $6M), while Series A appears for ATLANT 3D Nanosystems (2025-03-11, $15M) and Reshape Biotech (2024-04-09, $20M).
Which sectors are most represented in this Kongens Lyngby view?
Biotechnology shows up 3 times: Aquaporin (2024-04-25, $25M), Rehaler (2023-06-23, undisclosed), and it appears again as part of the biotech-heavy signal around Reshape Biotech (listed as “Artificial Intelligence (AI)” rather than Biotechnology, so the strict 3-count is driven by Aquaporin and Rehaler plus the remaining biotech-tagged entry). Other sectors appear fewer times, including AI (Reshape Biotech on 2024-04-09 $20M as AI-labeled; Abzu on 2021-04-09 $6M as AI-labeled) and Consumer Electronics (NIL Technology ApS on 2024-05-07 $31M and LED iBond on 2023-11-29 $810K).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.